Study Confirms Heart Risk of Erectile Dysfunction


By medpagetoday.com

As the severity of erectile dysfunction increases, so do the risks of cardiovascular disease and mortality among men both with and without a history of heart disease, researchers found.

Men with severe dysfunction in particular had significantly elevated risks of ischemic heart disease, heart failure, peripheral vascular disease, "other" cardiovascular disease, all cardiovascular diseases combined, and all-cause mortality (RRs 1.26 to 8.00), according to Emily Banks, MBBS, PhD, of Australian National University in Canberra, and colleagues.

The relationships were generally stronger among men with previously recorded cardiovascular disease, the researchers reported online in PLOS Medicine; they noted that the erectile dysfunction should be considered a marker for heart disease rather than a risk factor.

"The findings provide general support for the Princeton consensus that men with erectile dysfunction require assessment for cardiovascular disease risk," the authors wrote, "while the quantitative ability of erectile dysfunction to predict risk in the clinical setting, over and above clinically measured risk factors, requires specific testing."

The researchers examined data from the 45 and Up Study, a prospective, population-based investigation of both men and women 45 and older living in New South Wales, Australia. The current analysis included 95,038 men (mean age 62) who provided postal questionnaire data from 2006 to 2009 and were followed for hospitalizations and deaths using government databases.

Erectile dysfunction was assessed using a single question about how often the men were able to get and keep an erection firm enough for satisfactory sexual activity. Severe dysfunction – defined as an answer of "never" to that question – occurred in 2.2% of those ages 45 to 54, 6.8% of those ages 55 to 64, 20.2% of those ages 65 to 74, 50% of those ages 75 to 84, and 75.4% of those ages 85 and older.

There were 7,855 hospitalizations for cardiovascular disease through an average follow-up of 2.2 years, and 2,304 deaths through an average follow-up of 2.8 years.

Risks of both outcomes increased along with the severity of erectile dysfunction after adjustment for age, smoking, alcohol consumption, marital status, income, education, physical activity, body mass index, diabetes, and treatment for hypertension or hypercholesterolemia.

Among men with no prior cardiovascular disease, severe erectile dysfunction was associated with significantly greater risks of the following specific outcomes:

Heart failure (RR 8.00, 95% CI 2.64 to 24.20)
Atrioventricular and left bundle branch block (RR 6.62, 95% CI 1.86 to 23.56)
Peripheral atherosclerosis (RR 2.47, 95% CI 1.18 to 5.15)
All-cause mortality (RR 1.93, 95% CI 1.52 to 2.44)
Peripheral vascular disease (RR 1.92, 95% CI 1.12 to 3.29)
Acute myocardial infarction (RR 1.66, 95% CI 1.22 to 2.26)
Ischemic heart disease (RR 1.60, 95% CI 1.31 to 1.95)
All cardiovascular diseases combined (RR 1.35, 95% CI 1.19 to 1.53)
"Other" cardiovascular disease (RR 1.26, 95% CI 1.05 to 1.51)


Generally similar relationships were observed among men with a history of known cardiovascular disease, although the findings "should be interpreted with caution, since a number of treatments for cardiovascular disease increase the risk of erectile dysfunction," according to Banks and colleagues.

Erectile dysfunction is likely a "biomarker ... of the severity of underlying pathological processes such as atherosclerosis and endothelial dysfunction," they wrote.

"Although the pathophysiology of erectile dysfunction is multifactorial and includes arterial, neurogenic, hormonal, cavernosal, iatrogenic, and psychogenic causes, it is now widely accepted that erectile dysfunction is predominantly due to underlying vascular causes, particularly atherosclerosis," they wrote.

The researchers acknowledged that the study was limited by the lack of information on the duration of erectile dysfunction, on certain risk factors like blood pressure and lipids, and on medication use.

In addition, the study relied on self-reported data for most of the potential confounders and on administrative data for cardiovascular hospitalization endpoints. Unmeasured confounding was a possibility.

Source: http://www.medpagetoday.com/urology/erectiledysfunction/37126

fake cialis singapore http://cialissom.com/ cialis 20mg uses on-line cialis what is in generic cialis cheap cialis cialis and ear pain http://cialisles.com/ potenzprobleme trotz cialis

Tuesday, May 12, 2026

Penicillin V Penicillin Dosing Strategies That Maximize Strep Throat Healing and Prevent Recurrent Infection

Penicillin V penicillin dosing for strep throat follows established protocols that balance therapeutic effectiveness with safety across age groups and body weight categories. Understanding your specific dose and why your healthcare provider chose that strength supports treatment adherence and effective healing. Standard adult penicillin V dosing for strep throat typically involves moderate doses taken two to four times daily. The frequency and dose strength depend on infection severity, kidney function, other medications, and individual factors your healthcare provider assesses. Higher doses treat more severe infections while preventing unnecessary medication excess. Children require weight based penicillin V dosing that differs significantly from adult regimens. Pediatric doses account for smaller body mass and developing kidney function. Never adjust children's doses without professional instruction. Under dosing risks treatment failure while overdosing risks toxicity. Taking penicillin V exactly as labeled timing ensures consistent antibiotic blood levels that continuously suppress streptococcal bacteria. Spacing doses evenly throughout the day maintains therapeutic levels better than consolidating doses. Using phone reminders helps maintain consistent dosing schedule. A full ten day course of penicillin V represents the treatment standard for strep throat despite symptom improvement typically occurring within 24 to 48 hours. The extended course ensures complete bacterial elimination. Stopping early allows surviving streptococci to repopulate, causing recurrent infection. Missed doses should be taken as soon as remembered unless the next dose approaches. Never double dose to compensate for a missed dose. Continuing the regular schedule maintains steady antibiotic levels effectively. Learn about penicillin v penicillin dosing guidelines during your clinical visit. Ask your healthcare provider when to take doses relative to meals, whether food affects absorption, and what to do if you miss a dose. Penicillin V absorption improves on empty stomach compared to taking with meals. However, if stomach upset occurs, taking with food is acceptable despite slightly reduced absorption. The dose adjustment remains sufficient even with modest absorption reduction. Allergy history matters critically for penicillin V treatment decisions. If you've experienced previous penicillin reactions, inform your healthcare provider immediately. Alternative antibiotics exist for penicillin allergic patients, though some reaction histories allow penicillin V use with appropriate precautions. Kidney disease changes penicillin V elimination from the body, potentially requiring dose adjustment or extended dosing intervals. Your healthcare provider considers kidney function when determining appropriate dosing. Dialysis patients need specific penicillin V dosing adjusted to their treatment schedule. Penicillin V effectiveness remains high against streptococcal bacteria despite decades of clinical use. Unlike many antibiotic resistance concerns affecting other medications, strep sensitivity to penicillin V remains consistently strong. This sustained effectiveness makes penicillin V the preferred strep treatment option. Stomach upset occasionally occurs during penicillin V courses. Taking medication with food, eating regular meals, and maintaining adequate hydration minimize digestive effects. Diarrhea sometimes increases during antibiotic use due to normal intestinal flora disruption rather than medication toxicity. Continuing full treatment course despite symptom resolution is critical for preventing complications like rheumatic fever. Early treatment discontinuation increases relapse risk substantially. Understanding this risk helps motivate completing full therapy. For comprehensive guidance on strep throat management and evidence based antibiotic dosing, explore reliable approaches to streptococcal infection treatment. Appropriate penicillin V dosing and complete course compliance provide optimal protection against strep complications.

Friday, May 8, 2026

Comparing Allergy Care Costs Beyond the Pharmacy Shelf

Allergy care expenses often seem small in isolation, which is why many households do not notice how quickly they add up. One purchase for medicine here, another for tissues there, and a few extra cleaning supplies later can quietly turn a seasonal problem into a recurring budget issue. Looking at allergy management as a full system instead of a single purchase can lead to better decisions. Medication is usually the most obvious cost, but it is rarely the only one. Some people replace air filters more often, buy unscented skin products, add protective covers to bedding, or spend more on laundry because of repeated symptom flares. These changes may be worthwhile, but they still count toward the total cost of keeping symptoms under control. The next useful question is whether each purchase is solving the right problem. If symptoms improve after a few targeted changes, then the expense may be justified. If not, repeated spending may simply reflect uncertainty rather than progress. People sometimes buy new products because they are frustrated, not because those products clearly match the trigger or symptom pattern involved. That is why comparing medication value should go beyond the sticker price alone. Looking into benadryl diphenhydramine price information may help with one part of the decision, but value also includes convenience, side effects, and whether the product supports the person's daily routine. A lower price does not always mean better value if the medicine causes unwanted fatigue or is being used for the wrong type of symptom. Families can often improve both comfort and spending by combining smart prevention with careful symptom tracking. Reducing indoor dust, washing frequently used fabrics, and recognizing seasonal patterns may lower the need for repeated last minute purchases. Planning ahead is usually cheaper than reacting in the middle of a bad flare. Persistent symptoms also deserve honest review. If congestion, itching, or rash continues despite multiple purchases and routine changes, it may be time to involve a clinician rather than keep experimenting. Spending more without learning more is rarely the best long term strategy. People trying to make more practical choices can benefit from broader allergy guidance that explains triggers, treatments, and preventive habits. Better information helps households spend less reactively and build a more reliable plan for managing symptoms over time.